Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
Interindividual variability in drug efficacy and toxicity is a major challenge in clinical practice. Variations in drug pharmacokinetics (PKs) and pharmacodynamics (PDs) can be, in part, explained by polymorphic variants in genes encoding drug metabolizing enzymes and transporters (absorption, distr...
Main Authors: | Mariamena Arbitrio, Francesca Scionti, Maria Teresa Di Martino, Daniele Caracciolo, Licia Pensabene, Pierfrancesco Tassone, Pierosandro Tagliaferri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12869 |
Similar Items
-
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
by: Maria Teresa Di Martino, et al.
Published: (2020-06-01) -
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
by: Francesca Scionti, et al.
Published: (2022-01-01) -
Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation
by: Massimiliano Fonsi, et al.
Published: (2024-01-01) -
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
by: Tagliaferri Pierosandro, et al.
Published: (2009-10-01) -
DMET-Analyzer: automatic analysis of Affymetrix DMET Data
by: Guzzi Pietro, et al.
Published: (2012-10-01)